Rilonacept In February 2008, the interleukin 1 blocker rilonacept was FDA approved for the treatment of a group of rare autoinflammatory diseases. 2 May 2008
Rilonacept
An analysis of the factors that determine the size of the world's fastest-growing pharmaceutical market. 2 May 2008
